Eureka Forbes Q4 FY26 Revenue up 11.6% to ₹683.8 Cr; Highest Ever EBITDA Margin at 13.2%
Eureka Forbes reported Q4 FY26 revenue of ₹683.8 Cr, up 11.6% YoY. Adjusted EBITDA margin hit a record high of 13.2%. Full-year FY26 revenue grew 11.3% to ₹2,710.5 Cr with a 12.2% Adjusted EBITDA margin. The company aims for over 2x revenue and 3x EBITDA in 5 years.
The announcement includes key financial performance indicators like revenue growth and record margins, which are material for investors. The forward-looking statements regarding future growth targets also indicate a high impact.
The company reported strong revenue growth, record high EBITDA margins, and significant increases in profitability metrics for both the quarter and the full year. Management commentary is optimistic about future growth.
Eureka Forbes Limited has announced its financial results for the quarter and full financial year ended March 31, 2026. For the fourth quarter of FY26, the company reported a standalone revenue growth of 11.6% year-on-year (YoY), reaching ₹683.8 crore. This growth was primarily driven by double-digit increases in Water Purifiers and strong performance in Emerging Categories, alongside double-digit growth in the products business. The service business also maintained its momentum with double-digit growth in service bookings.
The company achieved its highest-ever Adjusted EBITDA margin at 13.2%, an expansion of 17 basis points YoY, with Adjusted EBITDA at ₹90.2 crore. Adjusted Profit Before Tax (PBT) saw an increase of 8.1% YoY to ₹73.5 crore. Profit After Tax (PAT) before exceptional items grew by 3.9% YoY to ₹51.1 crore, while reported PAT grew by 0.7% YoY.
For the full financial year ended March 31, 2026, Eureka Forbes recorded double-digit revenue growth for the second consecutive year, with an 11.3% increase to ₹2,710.5 crore. Gross margins remained resilient, increasing by 46 basis points to 58.8%. Adjusted EBITDA increased by 16.4% YoY to ₹331.9 crore, with the Adjusted EBITDA margin expanding by 55 basis points to 12.2%, marking the third consecutive year of margin expansion. PAT before exceptional items grew by 19.3% to ₹190.2 crore, though reported PAT degrew by 1.9% to ₹160.2 crore. The company's Net Surplus reached an all-time high of ₹443.3 crore.
Mr. Pratik Pota, MD and CEO, highlighted the strong performance despite a challenging environment, emphasizing the quality of growth, transformation into a multi-category health and hygiene company, and a stronger balance sheet. He expressed confidence in delivering sustained, profitable growth through continued investments and sharper execution.
What to do with a filing like this
Eureka Forbes Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Eureka Forbes Limited. Read the original for the full detail.